Literature DB >> 21127507

Pseudoexfoliation as a risk factor for peripheral vascular disease: a case-control study.

M R Praveen1, S K Shah, A R Vasavada, R P Diwan, S M Shah, B R Zumkhawala, R Thomas.   

Abstract

AIM: To determine the association between pseudoexfoliation (PEX) and peripheral vascular disease (PVD) among age-related cataract.
SETTING: Iladevi Cataract and IOL Research Center, Ahmedabad, India.
MATERIAL AND METHODS: An observational age-matched case-control study of 160 patients over 60 years of age with age-related cataract. A total of 40 subjects with PEX (cases) were compared with 120 subjects with cataract but without PEX (controls). A detailed medical history, including hypertension, diabetes mellitus, cerebrovascular stroke and ischaemic heart disease, was recorded. Ankle brachial index (ABI) was used to determine the risk of PVD among age-related cataract patients. Color Doppler imaging was performed on the brachial and dorsalis pedis artery to measure ABI and detect PVD. Least mean ABI was the main outcome measure, as low ABI indicates higher risk for PVD. The lowest mean ABI was measured for each subject. An ABI ratio of <0.90 was considered abnormal. The Mann-Whitney U-test and logistic regression were used for analysis.
RESULTS: The lowest mean ABI in the controls was 0.98 ± 0.03 (SD; a range of 0.86-1.08) as compared with 0.88 ± 0.02 (SD) among the cases (a range of 0.79-0.92; P < 0.001). When compared with controls, cases had a lower ABI (P < 0.001) irrespective of the presence or absence of systemic illness. On multiple regression analysis adjusting for systemic illness, the presence of PEX increased the odds of a low ABI group 150 times (P < 0.001).
CONCLUSION: Subjects with cataract and PEX had a significantly lower ABI as compared with controls (cataracts without PEX). PEX is associated with and may be a risk factor for PVD.

Entities:  

Mesh:

Year:  2010        PMID: 21127507      PMCID: PMC3169212          DOI: 10.1038/eye.2010.175

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  25 in total

1.  Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation.

Authors:  K R Shrum; M G Hattenhauer; D Hodge
Journal:  Am J Ophthalmol       Date:  2000-01       Impact factor: 5.258

2.  Prevalence and surgical complications of pseudoexfoliation syndrome in Portuguese patients with senile cataract.

Authors:  M Alfaiate; E Leite; J Mira; J G Cunha-Vaz
Journal:  J Cataract Refract Surg       Date:  1996-09       Impact factor: 3.351

Review 3.  Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations.

Authors:  G O Naumann; U Schlötzer-Schrehardt; M Küchle
Journal:  Ophthalmology       Date:  1998-06       Impact factor: 12.079

4.  Association of pseudoexfoliation syndrome with increased vascular risk.

Authors:  P Mitchell; J J Wang; W Smith
Journal:  Am J Ophthalmol       Date:  1997-11       Impact factor: 5.258

Review 5.  The role of ankle brachial index and carotid intima-media thickness in vascular risk stratification.

Authors:  Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Curr Opin Cardiol       Date:  2010-07       Impact factor: 2.161

6.  Color Doppler imaging of the ophthalmic artery blood flow spectra of patients who have had a transient ischemic attack. Correlations with generalized iris transluminance and pseudoexfoliation syndrome.

Authors:  L P Repo; M T Suhonen; M E Teräsvirta; K J Koivisto
Journal:  Ophthalmology       Date:  1995-08       Impact factor: 12.079

7.  Pseudoexfoliation syndrome: clinical factors related to capsular rupture in cataract surgery.

Authors:  J Moreno; S Duch; J Lajara
Journal:  Acta Ophthalmol (Copenh)       Date:  1993-04

8.  Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.

Authors:  A B Newman; D S Siscovick; T A Manolio; J Polak; L P Fried; N O Borhani; S K Wolfson
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

9.  Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome.

Authors:  B W Streeten; Z Y Li; R N Wallace; R C Eagle; A A Keshgegian
Journal:  Arch Ophthalmol       Date:  1992-12

10.  Elastosis of the lamina cribrosa in pseudoexfoliation syndrome with glaucoma.

Authors:  P A Netland; H Ye; B W Streeten; M R Hernandez
Journal:  Ophthalmology       Date:  1995-06       Impact factor: 12.079

View more
  21 in total

1.  Nailfold capillary morphology in exfoliation syndrome.

Authors:  C C Cousins; J H Kang; C Bovee; J Wang; S H Greenstein; A Turalba; L Q Shen; S Brauner; T Boumenna; S Blum; H Levkovitch-Verbin; R Ritch; J L Wiggs; P A Knepper; L R Pasquale
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

2.  Electroneuromyographic findings in pseudoexfoliation syndrome.

Authors:  Deniz Turgut Coban; Tuncay Cakir; Muhammet Kazim Erol; Gulsum Dogan; Berna Dogan; Meral Bilgilisoy Filiz; Naciye Fusun Toraman
Journal:  Int Ophthalmol       Date:  2017-04-12       Impact factor: 2.031

3.  Retinal vessel diameters and their correlation with retinal nerve fiber layer thickness in patients with pseudoexfoliation syndrome.

Authors:  Mehmet Cuneyt Ozmen; Zeynep Aktas; Burcin Kepez Yildiz; Murat Hasanreisoglu; Berati Hasanreisoglu
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

4.  YKL-40 is a local marker for inflammation in patients with pseudoexfoliation syndrome.

Authors:  Tansu Gonen; Savas Guzel; Kadircan H Keskinbora
Journal:  Eye (Lond)       Date:  2018-12-18       Impact factor: 3.775

Review 5.  Genetics of glaucoma.

Authors:  Janey L Wiggs; Louis R Pasquale
Journal:  Hum Mol Genet       Date:  2017-08-01       Impact factor: 6.150

6.  Pseudoexfoliation syndrome and coronary artery ectasia.

Authors:  M O Akdemir; M R Sayin; M Armut; I Akpinar; S H Ugurbas
Journal:  Eye (Lond)       Date:  2014-03-07       Impact factor: 3.775

7.  Plasma adropin level in patients with pseudoexfoliation.

Authors:  Tevfik Oğurel; Reyhan Oğurel; Mustafa Topuz; Nurgül Örnek; Kemal Örnek
Journal:  Int Ophthalmol       Date:  2016-02-10       Impact factor: 2.031

8.  Association of ocular pseudoexfoliation syndrome with ischaemic heart disease, arterial hypertension and diabetes mellitus.

Authors:  Martynas Spečkauskas; Abdonas Tamošiūnas; Vytautas Jašinskas
Journal:  Acta Ophthalmol       Date:  2012-05-02       Impact factor: 3.761

Review 9.  Genomic and proteomic pathophysiology of pseudoexfoliation glaucoma.

Authors:  Luis E Vazquez; Richard K Lee
Journal:  Int Ophthalmol Clin       Date:  2014

10.  Link of ocular pseudoexfoliation syndrome and vascular system changes: results from 10-year follow-up study.

Authors:  Ugnė Rumelaitienė; Dalia Žaliūnienė; Martynas Špečkauskas; Abdonas Tamošiūnas; Ričardas Radišauskas; Emilija Jusevičiūtė; Vidas Vainauskas; Gailutė Bernotienė
Journal:  Int Ophthalmol       Date:  2020-01-19       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.